Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum
- 4 September 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (38), 15395-15400
- https://doi.org/10.1073/pnas.1204366109
Abstract
Sensitive detection of low-abundance proteins in complex biological samples has typically been achieved by immunoassays that use antibodies specific to target proteins; however, de novo development of antibodies is associated with high costs, long development lead times, and high failure rates. To address these challenges, we developed an antibody-free strategy that involves PRISM (high-pressure, high-resolution separations coupled with intelligent selection and multiplexing) for sensitive selected reaction monitoring (SRM)–based targeted protein quantification. The strategy capitalizes on high-resolution reversed-phase liquid chromatographic separations for analyte enrichment, intelligent selection of target fractions via on-line SRM monitoring of internal standards, and fraction multiplexing before nano–liquid chromatography-SRM quantification. Application of this strategy to human plasma/serum demonstrated accurate and reproducible quantification of proteins at concentrations in the 50–100 pg/mL range, which represents a major advance in the sensitivity of targeted protein quantification without the need for specific-affinity reagents. Application to a set of clinical serum samples illustrated an excellent correlation between the results obtained from the PRISM-SRM assay and those from clinical immunoassay for the prostate-specific antigen level.Keywords
This publication has 41 references indexed in Scilit:
- Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay testsJournal of Proteomics, 2012
- Advancing the sensitivity of selected reaction monitoring‐based targeted quantitative proteomicsProteomics, 2012
- A targeted proteomics–based pipeline for verification of biomarkers in plasmaNature Biotechnology, 2011
- A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular diseaseNature Biotechnology, 2011
- Reversed‐phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cellsProteomics, 2011
- Full Dynamic Range Proteome Analysis of S. cerevisiae by Targeted ProteomicsCell, 2009
- Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasmaNature Biotechnology, 2009
- Expediting the Development of Targeted SRM Assays: Using Data from Shotgun Proteomics to Automate Method DevelopmentJournal of Proteome Research, 2009
- Selected reaction monitoring for quantitative proteomics: a tutorialMolecular Systems Biology, 2008
- Protein biomarker discovery and validation: the long and uncertain path to clinical utilityNature Biotechnology, 2006